Talk To Your DNA: Startup Bystro AI Launches ChatGPT For Genetics To Decode Health, Stress, And Personality – Yahoo! Tech
Manage your account
AI
Audio
Computing
Gaming
Home entertainment
Phones
Puzzle hints
Science
Streaming
Tech news
VPN
Deals
More
…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Technology startup Bystro AI has developed a platform that transforms genetic data into conversational outputs. The company was founded by Alex Kotlar, who pursued a career in genetics after leaving Chernobyl and losing family members to malignancy, according to Bystro AI's website.
Kotlar created the venture to make genomic analysis more accessible to researchers, clinicians, and individuals. The platform enables users to interact with their genetic information through natural-language questions rather than using code or computational pipelines.
According to Boston-based Bystro, the technology is designed to help users "form a deeper relationship with yourself by talking to your DNA," enabling them to explore how genetic patterns may influence areas such as health, stress response and personality traits.
Don't Miss:
Accredited Investors Can Now Tap Into the $36 Trillion Home Equity Market — Without Buying a Single Property
If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?
The conventional pathway to genomic research involves considerable complexity, Bystro says. Scientists typically invest months navigating software dependencies, troubleshooting code libraries, and managing technical infrastructure to comprehend their information. Bystro’s system removes these hurdles by accepting inquiries formulated in standard English.
Users can transfer genomic information from sources including 23andMe, AncestryDNA, and MyHeritage into the platform. Upon uploading, they phrase their inquiries naturally. Questions such as “What is causing my perpetual exhaustion?” or “Do I require vitamin D supplementation?” receive computational responses within seconds, as outlined on Bystro’s website.
For institutional users, the platform generates more sophisticated analytical capabilities. Research centers can submit requests for comparative protein analysis between disease samples, molecular classification within patient populations, or validation of hereditary susceptibility calculations across varied ethnic backgrounds. According to Bystro, investigators obtain visualization diagrams, statistical measurements, and results formatted for scholarly publications, all within brief timeframes.
Trending: The ‘ChatGPT of Marketing' Just Opened a $0.81/Share Round — 10,000+ Investors Are Already In
Bystro AI's scope spans genomics, proteomics, and pharmacogenomics. The platform claims to offer ancestry-corrected polygenic risk scores, variant-protein correlation, and visualizations such as volcano plots.
While the company currently emphasises research-use rather than clinical-diagnostic applications, the eventual goal includes helping individuals understand why they might feel more fatigued, respond differently to caffeine, or experience atypical supplement response based on their genetics.
One participant, identified as Mason on the platform, reported discovering through examination that his body exhibits reduced vitamin D assimilation, challenged digestion of beef products, and unidentified dairy sensitivity.
"I used to feel tired and drained after eating and thought maybe I had some kind of mental issue or needed antidepressants, but it turned out to be lactose," Mason said, according to Bystro AI. Upon discovering his lactose response through the platform, he modified his nutritional intake.
Another user, Ezgi, found through the analysis that her dermatological concerns were connected to gluten responsiveness, while her recurring head sensations resulted from sluggish caffeine metabolism. Following these discoveries, Ezgi said she adjusted her routine and reported improved rest quality despite decreasing her sleep duration.
See Also: Microsoft's Climate Innovation Fund Just Backed This Farmland Manager — And Accredited Investors Can Join the Same Fund
The genomics field produces significant economic value each year, yet access remains limited because interpreting genetic data often requires advanced technical knowledge. A Nova One Advisor report found that the global genomics data analysis market was valued at $6.85 billion in 2024 and is projected to reach $28.74 billion by 2034, adding that the cost and complexity of data interpretation continue to restrict broader adoption.
Bystro AI says it aims to reduce that gap by giving users a way to engage directly with their own genetic information through a simplified interface.
According to the company's mission statement, Bystro was created to make tools for exploring disease mechanisms more accessible, enabling users to focus on biological understanding rather than software management.
Read Next: Missed Tesla? EnergyX Is Tackling the Next $200 Billion Opportunity — Lithium
Image: Shutterstock
This article Talk To Your DNA: Startup Bystro AI Launches ChatGPT For Genetics To Decode Health, Stress, And Personality originally appeared on Benzinga.com
AI
Audio
Computing
Gaming
Home Entertainment
Phones
Puzzle hints
Science
Streaming
VPN
Wearables
Deals
Advertise
About our ads
Licensing
Careers
Help
Feedback
Sitemap
Follow us on
© 2025 Yahoo. All rights reserved.
